✦ LIBER ✦

Altered Invariant Natural Killer T cell Subsets and its Functions in Patients with Oral Squamous Cell Carcinoma

✍ Scribed by Singh, A. K.; Shukla, N. K.; Das, S. N.

Book ID: 121002001
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 456 KB
Volume: 78
Category: Article
ISSN: 0300-9475
DOI: 10.1111/sji.12104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T-cell subsets and natural killer cell a

T-cell subsets and natural killer cell activity in patients with gestational, trophoblastic neoplasia

✍ P-C Ho; JWM Lawton; L-C Wong; H-K Ma 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 255 KB

T-cell subsets and natural killer cell a

T-cell subsets and natural killer cell activity in patients with gestational trophoblastic neoplasia

✍ Ho, Pak-Chung; Lawton, John W.M.; Wong, Ling-Chui; Ma, Ho-Kei 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 439 KB

Invariant natural killer T cells are phe

Invariant natural killer T cells are phenotypically and functionally altered in Fabry disease

✍ Pereira, Catia S.; Azevedo, Olga; Maia, M. Luz; Dias, Ana F.; Sa-Miranda, Clara; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 846 KB

Transfusion History, T Cell Subsets and

Transfusion History, T Cell Subsets and Natural Killer Cytotoxicity in Patients with Colorectal Cancer

✍ Paul Ian Tartter; Bryan Steinberg; Deborah M. Barron; Giorgio Martinelli 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB

T-Lymphocyte Subsets in Patients with Sq

T-Lymphocyte Subsets in Patients with Squamous Cell Carcinoma of the Head and Neck

✍ Furusaka, Tohru; Yokode, Yutaka; Nakajima, Misako; Iida, Hidenobu; Kida, Akinori 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 774 KB

Defective function of lymphokine-activat

Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma

✍ Toshiji Saibara; Saburo Onishi; Hiroshi Sakaeda; Yasutake Yamamoto 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Lymphokine-activated killer activity and natural killer activity in hepatocellular carcinoma patients were d. Maximum lymphokine-activated killer activity was induced at 3 to 6 days of incubation, and lymphokine-activated killer activity tended to increase in a manner dose dependent of recombinant i